Press Release: Itepekimab met the primary endpoint in one of two COPD phase 3 studies

1 day ago 4
ARTICLE AD BOX
Read Entire Article
  1. Homepage
  2. Finance
  3. Press Release: Itepekimab met the primary endpoint in one of two COPD phase 3 studies

Related

EU Commission 'strongly' regrets announced increase in US steel tariffs

EU Commission 'strongly' regrets announced increase in US st...

2 hours ago 0
ispace Completes Success 8 of Mission 2 Milestones

ispace Completes Success 8 of Mission 2 Milestones

2 hours ago 0
In Largest Molecular Residual Disease (MRD) Study in Colon Cancer, Guardant Reveal Testing Prior to Chemotherapy Provides Robust Stratification for Risk of Disease Recurrence and Survival to Enable Ti

In Largest Molecular Residual Disease (MRD) Study in Colon C...

2 hours ago 0
RIGHT SIDEBAR TOP AD

Trending

1. keri russell
2. kate middleton
3. sinner tennis
4. f1 qualifying time
5. sophie cunningham injury
6. fenerbahçe vs konyaspor
7. michael grimm
8. filip misolic
9. sloane stephens
10. flavio cobolli

Popular

What we know about the New York City helicopter crash that killed 6 people

What we know about the New York City helicopter crash that k...

1 month ago 198
Stanford 2025 AI Index Reveals Surge in Adoption, Investment, and Global Impact as Trust and Regulation Lag Behind

Stanford 2025 AI Index Reveals Surge in Adoption, Investment...

1 month ago 151
Western Governors University Joins Open edX as a Mission-Aligned Organization

Western Governors University Joins Open edX as a Mission-Ali...

2 months ago 138
Microsoft Adds New Agentic AI Tools to Security Copilot

Microsoft Adds New Agentic AI Tools to Security Copilot

1 month ago 133
New AI Tool Generates Video Explanations Based on Course Materials

New AI Tool Generates Video Explanations Based on Course Mat...

2 months ago 130
RIGHT SIDEBAR BOTTOM AD
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Powerbits - breaking news today 2025. All rights are reserved